DIALYSIS · CCN 332639

USRC South Flushing

FLUSHING, NY 11365

DialysisProfitUS Renal Care, Inc.
$5.7M
TOTAL REVENUE
-19.6%
OPERATING MARGIN
5 / 5
STAR RATING
15
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$5.7M
Total costs
$6.9M
Operating income (rev − costs)
−$1.1M
Operating margin
-19.6%
Total charges
$5.7M
Total treatments
19,105
Dialysis stations
24

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

15 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
98146—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.3864—
Fistula Rate
DFC_FISTULA_RATE
87.1155—
Five Star Rating
DFC_FIVE_STAR
5——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.4971—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
143129—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
0151—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.14——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
3155—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
13.4598—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
36.7104—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
31.599—
Standardized ED Visits Ratio
DFC_SEDR
0.4852—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
8.243—